{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T15:13:15Z","timestamp":1693062795349},"reference-count":37,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T00:00:00Z","timestamp":1179705600000},"content-version":"vor","delay-in-days":1601,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:p> <jats:italic>African Americans experience more mortality and morbidity from hypertension\u2010related complications than other racial groups. Although angiotensin\u2010converting enzyme (ACE) inhibitors have clearly been shown to reduce mortality and morbidity in hypertensive white patients with heart failure, renal dysfunction, stroke, and acute myocardial infarction, African American patients have been underrepresented in these trials. The lack of direct evidence of the benefit of ACE inhibitors in these individuals and the suggestion that ACE inhibitors are less efficacious in this group has resulted in a reluctance to use ACE inhibitors in African Americans. However, retrospective analyses in black patients with heart failure and a recent randomized clinical trial in African Americans with renal dysfunction suggest that a regimen based on ACE inhibitors is efficacious in this racial group. Although diuretics remain first\u2010line therapy, data now suggest that ACE inhibitors provide additional benefit and should be considered for use in patients with high\u2010risk complications regardless of race.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1524-6175.2003.suppmakeup.x","type":"journal-article","created":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T17:21:50Z","timestamp":1179768110000},"page":"26-31","source":"Crossref","is-referenced-by-count":1,"title":["Treatment of High\u2010Risk African American Patients: Left Ventricular Dysfunction, Heart Failure, Renal Disease, and Postmyocardial Infarction"],"prefix":"10.1111","volume":"5","author":[{"given":"Rohit","family":"Arora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luther","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,5,21]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70237-1"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1054\/jcaf.2000.17610"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90456-B"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902253400804"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441802"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.14.1411"},{"key":"e_1_2_8_8_2","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","author":"Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","year":"1993","journal-title":"Lancet"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162301"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512213332503"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271001"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271003"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108013250501"},{"key":"e_1_2_8_14_2","first-page":"767","article-title":"Race and responsiveness to drugs for heart failure [letter]","volume":"345","author":"Ofili E","year":"2001","journal-title":"N Engl J Med"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000578"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00040031707020"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01943-5"},{"key":"e_1_2_8_18_2","unstructured":"American College of Clinical Cardiology\/American Heart Association.ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult. Available at:http:www.acc.org.Accessed September 5 2002."},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-9164(99)91340-4"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11445-8"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292004"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604113341502"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2719"},{"key":"e_1_2_8_24_2","volume-title":"2002 Heart and Stroke Statistical Update","author":"American Heart Association","year":"2001"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.2.415"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.11.1388"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460240051027"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2981"},{"key":"e_1_2_8_29_2","first-page":"126","article-title":"ACE inhibitors and stroke: new considerations","volume":"4","author":"Sica DA","year":"2000","journal-title":"J Clin Hypertens"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7339.699"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06178-5"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)12323-7"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199501123320203"},{"key":"e_1_2_8_35_2","first-page":"1115","article-title":"GISSI\u20103: effects of lisinopril and transdermal glyceryl trinitrate single and together on 6\u2010week mortality and ventricular function after acute myocardial infarction","volume":"343","author":"Gruppo Italiano per lo Studio della Sopravvivenz nell'infarto Miocardico","year":"1994","journal-title":"Lancet"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90865-X"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.10.3132"},{"key":"e_1_2_8_38_2","unstructured":"RyanTJ AntmanEM BrooksNH et al.ACC\/AHA guidelines for the management of patients with acute myocardial infarction. Available at:http:www.americanheart.org.Accessed September 5 2002."}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1524-6175.2003.SuppMakeUp.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1524-6175.2003.SuppMakeUp.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1524-6175.2003.SuppMakeUp.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1524-6175.2003.SuppMakeUp.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T23:41:17Z","timestamp":1693006877000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1524-6175.2003.SuppMakeUp.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1111\/j.1524-6175.2003.SuppMakeUp.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-6175.2003.suppmakeup.x","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}